about
Susceptibility to HLA-DM Protein Is Determined by a Dynamic Conformation of Major Histocompatibility Complex Class II Molecule Bound with PeptideHuman cell-based artificial antigen-presenting cells for cancer immunotherapy.HLA-DM Focuses on Conformational Flexibility Around P1 Pocket to Catalyze Peptide Exchange.Mechanistic understanding and significance of small peptides interaction with MHC class II molecules for therapeutic applications.MHC class II complexes sample intermediate states along the peptide exchange pathway.
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
HLA-DM: arbiter conformationis.
@en
type
label
HLA-DM: arbiter conformationis.
@en
prefLabel
HLA-DM: arbiter conformationis.
@en
P2860
P356
P1433
P1476
HLA-DM: arbiter conformationis.
@en
P2093
Andrea Ferrante
P2860
P356
10.1111/IMM.12030
P577
2013-02-01T00:00:00Z